Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ENVBENVB
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ENVERIC BIOSCIENCES INC

Yes. Citadel Advisors holds 13,965 shares of ENVB (Enveric Biosciences), worth $19,272, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$19,272

Current Shares

13,965

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
13,965
-
$19,2720.0%$1.38
28

Other major holders of ENVB: GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, XTX Topco Ltd, HRT FINANCIAL LP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used